10年100例机器人重大肝切除术:单中心经验
该单中心回顾性研究分析了2012至2022年间100例机器人重大肝切除术,比较前50例(A组)与后50例(B组)的结局。结果显示两组在手术时间、出血量、住院时间、90天再入院、重大并发症及90天死亡率上无差异,但B组ICU入住率和中转率显著更低,而专家级难度指数更高。作者认为机器人重大肝切除术的学习曲线约在50例时趋于平台。
要点
- 前50例与后50例机器人重大肝切除术在手术时间、出血量、住院时间、90天再入院、重大并发症及90天死亡率上无差异。
- 后50例ICU入住率(14.0% vs 48.0%)和中转率显著低于前50例,而专家级难度指数更高(82% vs 58%)。
- 作者认为本机构机器人重大肝切除术的学习曲线约在50例时趋于平台。
核心结论
- 随时间推移,建立具有良好结局的机器人肝脏项目是可行的。
- 本机构数据显示机器人重大肝切除术的学习曲线约在50例时趋于平台。
研究设计与样本
- 单中心回顾性电子病历数据回顾。
- 2012年至2022年间共实施361例机器人肝脏手术,其中100例为重大肝切除术。
- 比较前50例(A组)与后50例(B组)的结局。
- 采用Wilcoxon秩和检验、χ2检验和逻辑回归模型进行统计分析,使用Stata v.17,显著性设定为p < .05。
主要发现
- A组与B组的中位手术时间分别为258分钟与256分钟,无差异。
- A组与B组的中位估计出血量均为500 mL,无差异。
- A组与B组的中位住院时间分别为5天与3.5天,无差异。
- A组与B组的90天再入院率分别为14%与24%,重大并发症发生率分别为14%与20%,90天死亡率分别为6%与4%,均无差异。
- B组ICU入住率显著低于A组(14.0% vs 48.0%),且B组专家级难度指数高于A组(82% vs 58%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Adoption of robotic liver resections has been gradually increasing throughout the HPB surgical community over the past decade. Currently there is limited literature which demonstrates a significant benefit of robotic surgery for major hepatectomies over open or laparoscopic. As one of the first centers to develop a robotic HPB program, we have experienced improved outcomes over time with increasing utilization of robotics. Herein, we present our 10-year experience and outcomes for major robotic liver resections. METHODS: From 2012 to 2022, 361 robotic liver procedures were performed, including 100 major hepatectomies. A retrospective data review of the electronic medical record was performed evaluating outcomes after robotic major hepatectomy. Outcomes for the first 50 cases (Group A) and second 50 cases (Group B) were compared to identify any improvements in practice. Demographic and clinical outcome variables were analyzed. Data were assessed for normality, and Wilcoxon rank-sum, χ2 tests, and a logistic regression model were performed appropriate for the data. Stata v.17 was utilized, and significance was set as p < .05. RESULTS: There was no difference in median operative time (258 vs 256 min), EBL (500 vs 500 mL), median LOS (5 vs 3.5 days), 90-day readmission (14% vs 24%), major complications (14% vs 20%), and 90-day mortality (6% vs 4%) between early and late cases, respectively. ICU admissions and conversion rates were significantly lower in group B (14.0% vs 48.0%), while expert level difficulty indices were higher (82% vs 58%). CONCLUSION: Development of a robotic liver program with good outcomes is feasible over time. Our data suggest that our institutional learning curve for robotic major hepatectomy plateaued at approximately 50 cases.
引用
- McCarron F, Cochran A, Ricker A, et al. 10 years, 100 robotic major hepatectomies: a single-center experience. Surg Endosc. 2023. PMID: 37845533. doi:10.1007/s00464-023-10459-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。